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INTRODUCTION
PET/CT can demonstrate both anatomic and meta-
bolic information in a single session (1). In PET/CT
systems, CT data is used for attenuation correction
of PET images, and imaging time can be shortened
because a transmission scan is not necessary as it is
with PET-alone systems. To improve image quality
in the CT part of PET/CT studies, oral contrast or
intravenous contrast agent can be given to distinguish
other structures or to observe contrast enhancement.
For CT-based attenuation corrected PET images, the
high attenuation associated with contrast can lead to
artifactual intense uptake in the corrected FDG images
(2-5). Intense uptake in the gastrointestinal tract ap-
pears to be seen more frequently in patients with oral
contrast compared to thosewithout contrast. Compared
to the PET annihilation photons of 511 keV, X-rays at
CT energies of 70-140 keV are more attenuated by the
structures that contain elements with high atomicnum-
bers, suchas iodineorbarium.Abilinear scalingmethod,
which distinguishes soft tissue frombone, is used to con-
vert different CTHounsfieldUnits (HU) into attenuation-
corrected PET images. To evaluate the degreeof FDG
uptake, standard uptake value (SUV) is used for quan-
titative analysis. The aim of this study is to evaluate the
hypothesis that the increased FDG uptake in gut seen
in patients who receive oral contrast is due to inaccurate
attenuation correction. If this is true then there should
be a strong correlation between FDG uptake (SUV)
and contrast density (HU) in these images.
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The correlation between SUV and HU in each separate location is not significant. When
all regions are combined, p value is significant (＜0.05), but R square is not significant. Oral
contrast can be one factor that influences measured FDG, and it is possible it acts as an
irritant that increases metabolism in the bowel wall, resulting in increased FDG uptake.
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PATIENTS AND METHODS
This study was approved by the University of Iowa
Institutional Review Board.
Patient population
Twenty contiguous patients without any history of
bowel diseasewere examined.Thepopulation consisted
of 9males and 11 females with age range of 29-79. The
indication for PET/CT was restaging/follow up of
lymphoma in 4 patients, breast cancer in 4, uterine
cervical cancer in 2, melanoma in 1, leukemia in 1, un-
known primary in 2, seminomatous tumor in 1, initial
staging for lung cancer in 1,melanoma in 1, evaluation
of lung nodules in 3. All studies were performedwith
a combined PET/CT scanner (Siemens, Biograph).
Fluoro-deoxyglucose (FDG) was producedwith a 17
meV Scandatronix cyclotron in our PET center.
The patients were asked to fast at least 4h before
FDG injection and blood glucose level was confirmed
below 150 mg/dl. Oral contrast of 750mlwas prepared
with the mixture of 37.5 ml iodine-based oral contrast
(Gastroview, 367mg iodine/ml, DiatrizoateMeglumine
and Diatrizoate Sodium Solution U.S.P, Mallinckrodt
Inc) and 712.5 ml of water. The patient took 500 ml
of oral contrast before 370-555MBq FDG intravenous
injection and another 250ml before positioning on the
PET/CT table. After positioning, a topogramwas taken
for scan range determination. Then a CT image was
obtained by 2-slice helical scanner. After the completion
of the CT image, the PET scan started 90minutes after
FDG injection from caudal to cranial direction. The
scan range was different according to the patient body
size and refered disease, typically consisting of 5-8
bed positions. Each bed position took 3 min and the
total time on the table was approximately 30 min.
Patients breathed freely during the whole study.
DATA ANALYSIS
CT-based attenuation corrected PET images, CT
images, fused images and uncorrected PET images
were displayed on the monitor for image interpreta-
tion. Using the fused PET/CT image, a region of in-
terest (ROI, 3-4cm2 in size) was placed manually on
oral contrast in the lumen of stomach, small bowel
and ascending colon, avoiding contamination by other
structures, and the average SUV and averageHUwas
determined. SUV was calculated as follows : SUV=
tissue concentration (kBq/ml)/injected FDG dose
(kBq)/body weight (g). If focal uptake was observed,
an ROI was placed on the most intense area visually.
R square and p value was determined to test the re-
lationship between SUV and HU, using linear corre-
lation. We calculated 3 sites separately toevaluatewithin
region relationships, and put the 3 sites together to
evaluate correlation across the entire gastrointestinal
tract.
RESULTS
Images are displayed in Fig.1a-attenuation corrected
PET image, b-CT image, c-PET/CT fused image, d-
uncorrected PET image. It is difficult to assess the
difference of CT density (HU) by visual assessment,
although FDG uptake in the ascending colon seems
to be more intense compared to that in the stomach
on both corrected and uncorrected PET images. The
distribution of SUVs and HUs is shown in Fig.2.
Both SUV andHUvariedover awide range.The results
of the linear correlation analysis are displayed inTable 1.
The correlation between SUV andHU in each separate
location is not significant. When all regions are com-
bined, p value is significant (＜0.05), indicating a slope
not equal to zero, but R square is not significant.
DISCUSSION
After we began to use FDG-PET/CTwith oral con-
trast, we noticed that intense uptake appeared to be
seen more frequently in the bowel when patients were
given oral contrast than without. These foci of intense
uptake are seen in attenuation corrected images and
Table 1. The results of R square and p value are displayed in Table 1. The correlation between SUV and HU is not significant.
meanSUVavr (SD) meanHUavr (SD) R square p value
stomach 1.10 (0.41) 296 (38) 0.005 0.77
small bowel 2.03 (0.57) 315 (112) 0.02 0.55
ascending colon 3.03 (0.55) 359 (68) 0.003 0.822
3 combination 2.05 (0.94) 323 (82) 0.097 0.016
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also in uncorrected PET images.We hypothesized that
an error in attenuation correction due to high concen-
tration of oral contrast is not the only factor affecting
measured FDGactivity. There are several reports about
the effect of oral contrast agents on theGI tract. Antoch
reported that the degree of attenuation overestimation
correlates with contrast concentration (2). According
to their data, FDG activity can be overestimated by
5-30% in clinically-used concentration. We used 5%
iodine-based oral contrast that shows approximately
315 HU. Our system uses 300 HU as a threshold to
distinguish soft tissue from bone for CT-based attenu-
ation correction. Since our data shows amounts of con-
trast in the range of 300-400 HU with SUVs varying
from 0.5 to 4.5, it is difficult to explain the variation in
SUV simply by variation of HU.Our data also showed
that the contrast concentration differs along the GI
tract. Thoughwe found little correlation between SUV
Fig 1. Forty-two year old female underwent FDG-PET/CT for restaging of breast cancer. a-corrected PET image, b-CT image, c-
fused image, d-uncorrected PET image. Oral contrast in the stomach and large bowel shows similar density visually. Intense uptake is
seen in both corrected and uncorrected PET images. SUVavr, HUavr in the stomach ; 0.87, 285, small bowel ; 1.58, 223, ascending colon ;
3.76, 338.
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and HU in separate GI locations, the p value was less
than 0.05 for the combination of all 3 regions. This
result supports the concept that contrast concentration
is one of the factors that influences measured FDG
activity.
In normal tissues or structures, SUV does not cor-
relate well with HU. Urine shows very small HU but
very high SUV because of FDG excretion from urinary
system. Brain parenchyma and heartmuscle show soft
tissue density onCT and commonly display very intense
FDG uptake because of the large demand of glucose
as an energy source in these tissues.
One limitation of this study is themovement of oral
contrast during the time between the CT scan and the
PET scan. We took PET images moving from caudal
to cranial to minimize the difference of location of oral
contrast between the two images. The time lag is up
to 10minutes in the upper abdomen. Peristalsis naturally
occurs through the scan and oral contrast in the lumen
moves distally. It is quite difficult to predict the degree
of bowel peristalsis, but it is unlikely to be sufficient
to explain our findings.
In conclusion, our study supports thehypothesis that
oral contrast concentration can influence measured
FDG activity by mechanisms other than attenuation
effects. It is possible it acts as an irritant that increases
metabolism in the bowel wall, resulting in increased
FDG uptake. Further investigation may be needed to
address this possibility.
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Fig 2. The distribution of SUV and HU.
▲
: stomach,□ : small
bowel,
▲
: ascending colon. HU is most widely ranged in small
bowel. Trendline equation for the stomach ; Y= -0.0007 X＋1.32,
small bowel ; Y=0.0007 X＋0.81, large bowel ; Y=0.0004 X＋0.88,
3 combination ; Y=0.0036 X＋0.89
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